EHD2 is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast Carcinoma

EHD2 is a mechanotransducing ATPase localized in caveolae invaginations at the plasma membrane. EHD2 has recently been associated with several human cancers, however the significance of EHD2 transcript levels in cancer prognosis remains debated. Breast cancer is the most commonly occurring cancer in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Wei-Wei, Bièche, Ivan, Fuhrmann, Laetitia, Vacher, Sophie, Vincent-Salomon, Anne, Torrino, Stéphanie, Lamaze, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224205/
https://www.ncbi.nlm.nih.gov/pubmed/32409676
http://dx.doi.org/10.1038/s41598-020-65054-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224205/
https://www.ncbi.nlm.nih.gov/pubmed/32409676
http://dx.doi.org/10.1038/s41598-020-65054-5

Ejemplares similares